SCHEMBL4718323

SCHEMBL4718323

COC(=O)Oc1cc(C(=O)NCc2ccncc2)ncn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 6/20 0.52
SMN1; SMN2 Q16637 4/20 0.50
GAA P10253 1/20 0.47
LMNA P02545 2/20 0.46
POLB P06746 1/20 0.46
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
MAPK1 P28482 2/20 0.43
CSF1R P07333 1/20 0.43
AKT1 P31749 1/20 0.43
MAPK8 P45983 1/20 0.43
MAPK9 P45984 1/20 0.43
CSNK2A1 P68400 1/20 0.43
NTRK2 Q16620 1/20 0.43
PRKD2 Q9BZL6 1/20 0.43
PLK3 Q9H4B4 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MMP2 P08253 1/20 0.43
CYP3A4 P08684 1/20 0.43
STAT3 P40763 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4699659 0.89 MMP13 (0.68) MMP13SMN1; SMN2POLBHSD17B10
SCHEMBL4720402 0.88 MMP13 (0.58) MMP13SMN1; SMN2GAALMNAPOLB
SCHEMBL5616122 0.82 MMP13 (0.61) MMP13SMN1; SMN2GAALMNAPOLB
SCHEMBL4717001 0.81 MMP13 (0.56) MMP13SMN1; SMN2LMNAHSD17B10CYP3A4
SCHEMBL4718343 0.81 MMP13 (0.74) MMP13POLBMAPK1CYP3A4HTT
SCHEMBL4720400 0.78 MMP13 (0.70) MMP13SMN1; SMN2GAALMNAMAPK1
SCHEMBL4719389 0.77 RAB9A (0.53) MMP13POLBRAB9ANPC1MAPK1
SCHEMBL8348717 0.76 ROCK1 (0.65) MMP13SMN1; SMN2LMNARAB9AHSD17B10
SCHEMBL7630281 0.72 MMP13 (0.66) MMP13SMN1; SMN2LMNAPOLBRAB9A
SCHEMBL5615854 0.72 MMP13 (0.86) MMP13SMN1; SMN2GAALMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1560815-B1 NOVEL PYRIMIDINE-4,6-DICARBOXAMIDES FOR THE SELECTIVE INHIBITION OF COLLAGENASES SANOFI AVENTIS DEUTSCHLAND (DE) 2008-03-12 EP disclosed
EP-1560815-A1 NOVEL PYRIMIDINE-4,6-DICARBOXAMIDES FOR THE SELECTIVE INHIBITION OF COLLAGENASES Aventis Pharma Deutschland GmbH (DE) 2005-08-10 EP disclosed
WO-2004041788-A1 NOVEL PYRIMIDINE-4,6-DICARBOXAMIDES FOR THE SELECTIVE INHIBITION OF COLLAGENASES AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-05-21 WO disclosed